Oliver Darlington

580 total citations
28 papers, 368 citations indexed

About

Oliver Darlington is a scholar working on Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Oliver Darlington has authored 28 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Oliver Darlington's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Diabetes Treatment and Management (7 papers) and HIV-related health complications and treatments (4 papers). Oliver Darlington is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Diabetes Treatment and Management (7 papers) and HIV-related health complications and treatments (4 papers). Oliver Darlington collaborates with scholars based in United Kingdom, Sweden and United States. Oliver Darlington's co-authors include Phil McEwan, Eirini Palaka, Susan Grandy, Klas Bergenheim, Heleen van Haalen, John J.V. McMurray, Lei Qin, Michael Böhm, Mark C. Petrie and Kieran F. Docherty and has published in prestigious journals such as European Heart Journal, BMC Public Health and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Oliver Darlington

27 papers receiving 361 citations

Peers

Oliver Darlington
Patrick Henri France
Jiacong Luo United States
Louis Lind Plesner Denmark
Khawaja M. Talha United States
Ehimare Akhabue United States
Icilma Fergus United States
Carolyn Bauer United States
Szu‐Ying Lee Taiwan
Adam Shardlow United Kingdom
Syed Saad Canada
Patrick Henri France
Oliver Darlington
Citations per year, relative to Oliver Darlington Oliver Darlington (= 1×) peers Patrick Henri

Countries citing papers authored by Oliver Darlington

Since Specialization
Citations

This map shows the geographic impact of Oliver Darlington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Darlington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Darlington more than expected).

Fields of papers citing papers by Oliver Darlington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Darlington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Darlington. The network helps show where Oliver Darlington may publish in the future.

Co-authorship network of co-authors of Oliver Darlington

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Darlington. A scholar is included among the top collaborators of Oliver Darlington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Darlington. Oliver Darlington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hollard, D, Graham Roberts, Ian Taylor, Jane Whitney Gibson, & Oliver Darlington. (2024). HTA77 PICO Consolidation in European HTA Scoping: Examining PICO Variations in Oncology Drugs in the Context of the European Joint Clinical Assessment. Value in Health. 27(6). S258–S258. 2 indexed citations
3.
Darlington, Oliver, et al.. (2024). EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study. Value in Health. 27(6). S76–S76. 1 indexed citations
4.
Darlington, Oliver, et al.. (2023). HTA109 A Review of the Use of Indirect Treatment Comparisons to Support Health Technology Assessments in Ireland. Value in Health. 26(12). S339–S339. 1 indexed citations
5.
Jagrič, Timotej, Christine Brown, Dušan Fister, et al.. (2022). Toward an economy of wellbeing: The economic impact of the Welsh healthcare sector. Frontiers in Public Health. 10. 953752–953752. 1 indexed citations
6.
Allen, James, Oliver Darlington, Karen Hughes, & Mark A Bellis. (2022). The public health impact of loneliness during the COVID-19 pandemic. BMC Public Health. 22(1). 1654–1654. 11 indexed citations
7.
Jassem, Ahmed Majeed, et al.. (2021). Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment. PharmacoEconomics. 39(11). 1327–1341. 2 indexed citations
8.
Darlington, Oliver, Marc Evans, Phil McEwan, et al.. (2021). Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review. Advances in Therapy. 38(2). 994–1010. 40 indexed citations
9.
Darlington, Oliver, et al.. (2021). MO876ESTIMATING THE BUDGET IMPACT OF DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE FROM A UK PAYER PERSPECTIVE*. Nephrology Dialysis Transplantation. 36(Supplement_1). 3 indexed citations
10.
Matsumoto, Tetsuya, et al.. (2021). Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan. Journal of health economics and outcomes research. 8(2). 64–75. 8 indexed citations
11.
12.
13.
McEwan, Phil, Oliver Darlington, John J.V. McMurray, et al.. (2020). Cost-Effectiveness of Dapagliflozin as a Treatment for Heart Failure with Reduced Ejection Fraction: A Multinational Health-Economic Analysis of DAPA-HF. European Journal of Heart Failure. 22(11). 2147–2156. 96 indexed citations
14.
Gordon, Jason, Oliver Darlington, Phil McEwan, et al.. (2020). Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model. PharmacoEconomics. 38(8). 857–869. 23 indexed citations
15.
Palaka, Eirini, Susan Grandy, Heleen van Haalen, Phil McEwan, & Oliver Darlington. (2020). The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review. International Journal of Nephrology. 2020. 1–21. 65 indexed citations
16.
Palaka, Eirini, et al.. (2019). Associations between serum potassium and adverse clinical outcomes: A systematic literature review. International Journal of Clinical Practice. 74(1). e13421–e13421. 43 indexed citations
17.
Darlington, Oliver, et al.. (2018). Estimating Health Outcomes in HIV Infected Patients Treated with a Dual Regimen of Dolutegravir and Rilpivirine in Europe. Value in Health. 21. S155–S155. 2 indexed citations
18.
Arthurs, Erin, et al.. (2018). Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis. Value in Health. 21. S9–S10. 2 indexed citations
19.
Ward, Tom, et al.. (2018). PIN64 - DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF NAÏVE ADULTS LIVING WITH HIV-1: A UK COST-MINIMIZATION ANALYSIS. Value in Health. 21. S231–S232. 2 indexed citations
20.
McEwan, Phil, et al.. (2017). Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients. Value in Health. 20(9). A790–A790. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Henri Breakdown of academic impact, for papers by Jiacong Luo Breakdown of academic impact, for papers by Louis Lind Plesner Breakdown of academic impact, for papers by Khawaja M. Talha Breakdown of academic impact, for papers by Ehimare Akhabue Breakdown of academic impact, for papers by Icilma Fergus Breakdown of academic impact, for papers by Carolyn Bauer Breakdown of academic impact, for papers by Szu‐Ying Lee Breakdown of academic impact, for papers by Adam Shardlow Breakdown of academic impact, for papers by Syed Saad
Rankless by CCL
2026